About (2R)-1-[3-(4-bromothiophen-3-yl)-1,2,4-oxadiazol-5-yl]-3-phenylpropan-2-amine
(2R)-1-[3-(4-bromothiophen-3-yl)-1,2,4-oxadiazol-5-yl]-3-phenylpropan-2-amine (PubChem CID 166272061) has the molecular formula C15H14BrN3OS
and a molecular weight of 364.27 g/mol. Its IUPAC name is (2R)-1-[3-(4-bromothiophen-3-yl)-1,2,4-oxadiazol-5-yl]-3-phenylpropan-2-amine.
Analyze (2R)-1-[3-(4-bromothiophen-3-yl)-1,2,4-oxadiazol-5-yl]-3-phenylpropan-2-amine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (2R)-1-[3-(4-bromothiophen-3-yl)-1,2,4-oxadiazol-5-yl]-3-phenylpropan-2-amine?
The IUPAC name of (2R)-1-[3-(4-bromothiophen-3-yl)-1,2,4-oxadiazol-5-yl]-3-phenylpropan-2-amine (CID 166272061) is (2R)-1-[3-(4-bromothiophen-3-yl)-1,2,4-oxadiazol-5-yl]-3-phenylpropan-2-amine.
What is the SMILES notation for (2R)-1-[3-(4-bromothiophen-3-yl)-1,2,4-oxadiazol-5-yl]-3-phenylpropan-2-amine?
The canonical SMILES for (2R)-1-[3-(4-bromothiophen-3-yl)-1,2,4-oxadiazol-5-yl]-3-phenylpropan-2-amine is N[C@H](Cc1ccccc1)Cc1nc(-c2cscc2Br)no1.
What is the InChIKey of (2R)-1-[3-(4-bromothiophen-3-yl)-1,2,4-oxadiazol-5-yl]-3-phenylpropan-2-amine?
The InChIKey is DOYFKMGEHQVVGI-LLVKDONJSA-N. The full InChI is InChI=1S/C15H14BrN3OS/c16-13-9-21-8-12(13)15-18-14(20-19-15)7-11(17)6-10-4-2-1-3-5-10/h1-5,8-9,11H,6-7,17H2/t11-/m1/s1.
What are the key properties of (2R)-1-[3-(4-bromothiophen-3-yl)-1,2,4-oxadiazol-5-yl]-3-phenylpropan-2-amine?
(2R)-1-[3-(4-bromothiophen-3-yl)-1,2,4-oxadiazol-5-yl]-3-phenylpropan-2-amine has a molecular weight of 364.27 g/mol, XLogP of 3.67, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-1-[3-(4-bromothiophen-3-yl)-1,2,4-oxadiazol-5-yl]-3-phenylpropan-2-amine is sourced from PubChem (CID 166272061), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).